Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience

Introduction: The goals of osteomyelitis therapy are successful control of infection and reconstruction of the bone. The gold standard for filling defects is the autologous bone graft. Bioactive glass S53P4 is an inorganic bone substitute. We compared the outcome of using bioactive glass (BAG) versu...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinhausen, Eva, Lefering, Rolf, Glombitza, Martin, Brinkmann, Nikolaus, Vogel, Carsten, Mester, Bastian, Dudda, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Copernicus GmbH 2021
Materias:
Original Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132459/
https://www.ncbi.nlm.nih.gov/pubmed/34084694
http://dx.doi.org/10.5194/jbji-6-73-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132459/
https://www.ncbi.nlm.nih.gov/pubmed/34084694
http://dx.doi.org/10.5194/jbji-6-73-2021

Ejemplares similares